Literature DB >> 2407346

Association of rare alleles of the Harvey ras protooncogene locus with lung cancer.

H Sugimura1, N E Caporaso, R V Modali, R N Hoover, J H Resau, B F Trump, J A Longergan, T G Krontiris, D L Mann, A Weston.   

Abstract

The hypothesis that rare variable nucleotide tandem repeat alleles of the Ha-ras-1 polymorphism are an inherited predisposing factor in human lung carcinogenesis has been evaluated in an age, race, and smoking matched case-control study. Twenty-three different alleles were identified by their restriction fragment length in DNA isolated from peripheral blood lymphocytes and were categorized into three groups: common; intermediate; and rare. The frequencies of rare alleles in blacks with either squamous cell carcinoma, large cell carcinoma, or small cell carcinoma were found to be significantly higher than those among groups of control subjects that were comprised of chronic obstructive pulmonary disease patients and patients with cancer at sites other than the lung. A similar trend which did not reach statistical significance was observed in whites. These data are consistent with the hypothesis that inheritance of Ha-ras-1 rare restriction fragment length alleles represents a genetic risk factor for some human lung cancers. The biological basis of this observation remains to be clarified, and it is possible that ethnic variations in rare allele frequencies are responsible for the differences noted. However, the data suggest that further evaluation of the Ha-ras-1 polymorphism as a marker of individual lung cancer susceptibility is warranted.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2407346

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Distribution of Ha-ras alleles in patients with colorectal cancer and Crohn's disease.

Authors:  R Klingel; P Mittelstaedt; W G Dippold; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

2.  Simultaneous detection of genetic and immunological markers in non-small cell lung cancer: prediction of metastatic potential of tumor.

Authors:  I Zborovskaya; A Gasparian; M Kitaeva; B Polotzky; N Tupitzin; Z Machaladze; S Gerasimov; M Shtutman; M Jakubovskaya; M Davidov; A Tatosyan
Journal:  Clin Exp Metastasis       Date:  1996-11       Impact factor: 5.150

3.  Ha-ras rare alleles in breast cancer susceptibility.

Authors:  K Conway; S Edmiston; D B Fried; B S Hulka; P A Garrett; E T Liu
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

4.  Analysis of Ha-ras 1 allele frequencies in hereditary non-polyposis colorectal cancer.

Authors:  P Jeevaratnam; P J Browett; N S Van de Water; J R Jass
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

5.  Ha-ras-1 alleles in Norwegian lung cancer patients.

Authors:  D Ryberg; T Tefre; S Ovrebø; V Skaug; L Stangeland; A Naalsund; R Baera; A L Børresen; A Haugen
Journal:  Hum Genet       Date:  1990-11       Impact factor: 4.132

6.  Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis.

Authors:  A Weston; J H Godbold
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

7.  Statistical models for genetic susceptibility in toxicological and epidemiological investigations.

Authors:  W W Piegorsch
Journal:  Environ Health Perspect       Date:  1994-01       Impact factor: 9.031

Review 8.  Pharmacogenetics: detecting sensitive populations.

Authors:  P G Shields
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

9.  Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis.

Authors:  A Weston; N E Caporaso; L S Perrin; H Sugimura; S Tamai; T G Krontiris; B F Trump; R N Hoover; C C Harris
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

10.  Allele diversity of the H-ras-1 variable number of tandem repeats in Norwegian lung cancer patients.

Authors:  D Ryberg; T Tefre; V Skaug; L Stangeland; S Ovrebø; A Naalsund; A L Børresen; A Haugen
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.